Clinical Trial Results TV
May 3, 2006: ISAR-REACT 2
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* Role of Adjunctive Abciximab Prior to PCI in ACS Pts Pretreated with Clopidogrel:
* Gp IIb/IIIa in PCI
* EPIC Trial: Long-term FU
* PCI in Gp IIb/IIIa Trials UA/NSTEMI Population
* Baseline Tn, Gp IIb/IIIa, & Outcomes in ACS
* Nonrandomized Data: Thienopyridine Pretreatment
* Benefit of Clopidogrel Pretreatment with PCI

The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.

The guest faculty, Dr. Steven Steinhubl, has indicated that he received research/grant
support, and is a consultant for, The sanofi-aventis Group and The Medicine's Company.



Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
10-18-2021 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted